Genetic heterogeneity of cardiomyopathy and its correlation with patient care
Open Access
- 30 October 2023
- journal article
- research article
- Published by Springer Nature in BMC Medical Genomics
- Vol. 16 (1) , 1-10
Abstract
Cardiomyopathy, which is a genetically and phenotypically heterogeneous pathological condition, is associated with increased morbidity and mortality. Genetic diagnosis of cardiomyopathy enables accurate phenotypic classification and optimum patient management and counseling. This study investigated the genetic spectrum of cardiomyopathy and its correlation with the clinical course of the disease. The samples of 72 Korean patients with cardiomyopathy (43 males and 29 females) were subjected to whole-exome sequencing (WES). The familial information and clinical characteristics of the patients were reviewed and analyzed according to their genotypes. Dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), left ventricular non-compaction cardiomyopathy, and restrictive cardiomyopathy was detected in 41 (56.9%), 25 (34.7%), 4 (5.6%), and 2 (2.8%) patients, respectively. WES analysis revealed positive results in 37 (51.4%) patients. Subsequent familial testing identified ten additional familial cases. Among DCM cases, 19 (46.3%) patients exhibited positive results, with TTN variants being the most common alteration, followed by LMNA and MYH7 variants. Meanwhile, among HCM cases, 15 (60%) patients exhibited positive results with MYH7 variants being the most common alteration. In six patients with positive results, extracardiac surveillance was warranted based on disease information. The incidence of worse outcomes, such as mortality and life-threatening arrhythmic events, in patients with DCM harboring LMNA variants, was higher than that in patients with DCM harboring TTN or MYH7 variants. Diverse genotypes were identified in a substantial proportion of patients with cardiomyopathy. Genetic diagnosis enables personalized disease surveillance and management.Keywords
All Related Versions
Funding Information
- the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (HR21C0198)
- The Bio and Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (NRF-2022R1A2C2091689)
This publication has 39 references indexed in Scilit:
- Cardiomyopathy Classification: Ongoing Debate in the Genomics EraBiochemistry Research International, 2012
- Pediatric Cardiomyopathy: Importance of Genetic and Metabolic EvaluationJournal of Cardiac Failure, 2012
- Update 2011: Clinical and Genetic Issues in Familial Dilated CardiomyopathyJACC, 2011
- Prevalence of Desmosomal Protein Gene Mutations in Patients With Dilated CardiomyopathyCirculation: Cardiovascular Genetics, 2010
- Diagnostic, Prognostic, and Therapeutic Implications of Genetic Testing for Hypertrophic CardiomyopathyJACC, 2009
- Prevalence of Fabry Disease in a Cohort of 508 Unrelated Patients With Hypertrophic CardiomyopathyJACC, 2007
- Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseasesEuropean Heart Journal, 2007
- Contemporary Definitions and Classification of the CardiomyopathiesCirculation, 2006
- Clinical and genetic issues in familial dilated cardiomyopathyJACC, 2005
- Mutations in Sarcomere Protein Genes as a Cause of Dilated CardiomyopathyNew England Journal of Medicine, 2000